“Alarming article on the vast number of new mRNA based drugs being developed. What dire consequences will come along with these new drugs?” Admin
She had a sparkling British accent and spoke crisply. Her responses to me were sprinkled with “brilliant” and “lovely.” She told me, “Now that first proof of concept”1 has been established, the next wave of mRNA products is coming down the pipeline with over $50 billion market share this year.2 She is a representative of Hanson Wade, a company producing the 3rd Annual mRNA-Based Therapeutics Summit (“Supercharging the Next Wave of efficacious mRNA Therapeutics & Vaccines). Her job is “curating the audience for the upcoming 3rd mRNA-Based Therapeutics Summit this July.” She was calling me because I requested information about the summit and provided my contact details as requested.
Read/Listen: Supercharging the Launch of mRNA Products Will Have Dire Consequences – America Out Loud
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr